BlackRock Fund Advisors’s SAGENT PHARMACEUTICALS INC COM STK (DE) SGNT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q3 | – | Sell |
-2,454,318
| Closed | -$36.8M | – | 4321 |
|
|
2016
Q2 | $36.8M | Buy |
2,454,318
+162,912
| +7% | +$2.44M | 0.01% | 1698 |
|
|
2016
Q1 | $27.9M | Buy |
2,291,406
+19,031
| +0.8% | +$232K | 0.01% | 1794 |
|
|
2015
Q4 | $36.2M | Buy |
2,272,375
+21,348
| +0.9% | +$340K | 0.01% | 1697 |
|
|
2015
Q3 | $34.5M | Buy |
2,251,027
+101,275
| +5% | +$1.55M | 0.01% | 1661 |
|
|
2015
Q2 | $52.3M | Buy |
2,149,752
+69,346
| +3% | +$1.69M | 0.01% | 1494 |
|
|
2015
Q1 | $48.4M | Buy |
2,080,406
+177,137
| +9% | +$4.12M | 0.01% | 1526 |
|
|
2014
Q4 | $47.8M | Buy |
1,903,269
+162,861
| +9% | +$4.09M | 0.01% | 1493 |
|
|
2014
Q3 | $54.1M | Buy |
1,740,408
+264,944
| +18% | +$8.24M | 0.02% | 1317 |
|
|
2014
Q2 | $38.2M | Buy |
1,475,464
+615,755
| +72% | +$15.9M | 0.01% | 1582 |
|
|
2014
Q1 | $20.1M | Buy |
859,709
+31,972
| +4% | +$747K | 0.01% | 1993 |
|
|
2013
Q4 | $21M | Buy |
827,737
+345,054
| +71% | +$8.76M | 0.01% | 1969 |
|
|
2013
Q3 | $9.85M | Buy |
482,683
+104,779
| +28% | +$2.14M | ﹤0.01% | 2372 |
|
|
2013
Q2 | $7.93M | Buy |
+377,904
| New | +$7.93M | ﹤0.01% | 2401 |
|